Skip to main content

Call for papers - Genomic research and clinical interventions for rare diseases

Genome Medicine is calling for submissions to a new Collection on genomic research and clinical advances in rare diseases, guest edited by Anna Lindstrand and Claudia Carvalho. Deadline 16 April 2025.

Call for papers - Translating the microbiome in health and disease

Genome Medicine is calling for submission to a new Collection on translating the microbiome in health and disease guest edited by Peggy Lai. Deadline 1 December 2024.

Call for papers - Tumor immune contexture in cancer progression and treatment

Genome Medicine is calling for submissions to a new Collection on Tumor immune contexture in cancer progression and treatment guest edited by Noel De Miranda. Deadline 30 September 2024.

Call for papers - Advances in healthy aging and age-related diseases

Genome Medicine is calling for submissions to a new Collection on advances in healthy aging and
age-related diseases, guest edited by Joris Deleen and Henne Holstege. Deadline 9 September 2024.

Reviews, Research Highlights and Commentaries

Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:


Research Highlights

Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)


Focus: The human microbiome in health and disease

Read the latest Research and and Reviews on the human microbiome in health and disease:

Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides
Langdon, A., Schwartz, D.J., Bulow, C. et al. Genome Med 13, 28 (2021)

Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Hayase, E., Jenq, R.R. Genome Med 13, 107 (2021)

Strain-level epidemiology of microbial communities and the human microbiome
Yan, Y., Nguyen, L.H., Franzosa, E.A. et al. Genome Med 12, 71 (2020).

Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma
Usyk, M., Pandey, A., Hayes, R.B. et al. Genome Med 13, 160 (2021).

Aims and scope

Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, cardiology, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries. 

Article collections

Special issue
New technology applications in health and disease
Guest editors: Fei Chen and Francisco De La Vega

Special issue
Advancing human genetics in underrepresented populations
Guest editors: Segun Fatumo and Krishna Aragam

Special issue
Dissecting the role of immune responses in complex brain disorders: translational and clinical insights
Guest editors: Philip de Jager and Carlos Cruchaga

Coronavirus Resource - Submit your latest research and discoveries
Guest editor: Junhua Li

Special issue
Targeting cancer evolution in the clinic
Guest editors: Razelle Kurzrock and Alberto Bardelli

See all article collections

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 10.4
    5-year Journal Impact Factor: 12.6
    Source Normalized Impact per Paper (SNIP): 2.375
    SCImago Journal Rank (SJR): 4.975

    Speed 2023
    Submission to first editorial decision (median days): 9
    Submission to acceptance (median days): 185

    Usage 2023
    Downloads: 2,331,772
    Altmetric mentions: 4,916

  • Peer Review Taxonomy

    This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here

    The following summary describes the peer review process for this journal:

    • Identity transparency: Single anonymized
    • Reviewer interacts with: Editor
    • Review information published: None

    We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.